{"version":"https://jsonfeed.org/version/1","title":"RESET REALIGN RESTART","home_page_url":"https://resetrealignrestart.com","description":"RESET REALIGN RESTART","author":{"name":"RESET REALIGN RESTART"},"items":[{"id":"https://resetrealignrestart.com/newsletter/f/site-selection-is-not-broken-its-misaligned","html_content":"

Why sponsors keep missing the sites they need most and what it costs them.

","url":"https://resetrealignrestart.com/newsletter/f/site-selection-is-not-broken-its-misaligned","title":"Site Selection Is Not Broken.It's Misaligned.","summary":"Why sponsors keep missing the sites they need most and what it costs them.","date_modified":"2026-06-01T14:09:11Z"},{"id":"https://resetrealignrestart.com/newsletter/f/socra-summit-canada-2016-%E2%86%92-still-unresolved-in-2026","html_content":"

In 2016, I stood in front of a room of clinical research professionals in Canada and asked a question that made people uncomfortable.

","url":"https://resetrealignrestart.com/newsletter/f/socra-summit-canada-2016-%E2%86%92-still-unresolved-in-2026","title":"SOCRA Summit Canada, 2016 → Still unresolved in 2026","summary":"In 2016, I stood in front of a room of clinical research professionals in Canada and asked a question that made people uncomfortable.","date_modified":"2026-05-27T15:53:33Z"},{"id":"https://resetrealignrestart.com/newsletter/f/research-infrastructure-strategy-is-no-longer-optional","html_content":"

It's Your Competitive Edge

","url":"https://resetrealignrestart.com/newsletter/f/research-infrastructure-strategy-is-no-longer-optional","title":"Research Infrastructure Strategy Is No Longer Optional. ","summary":"It's Your Competitive Edge","date_modified":"2026-05-11T20:57:25Z"},{"id":"https://resetrealignrestart.com/newsletter/f/site-selection-in-clinical-trials-it%E2%80%99s-not-broken","html_content":"

It’s Misaligned

","url":"https://resetrealignrestart.com/newsletter/f/site-selection-in-clinical-trials-it%E2%80%99s-not-broken","title":"Site Selection in Clinical Trials: It’s Not Broken,","summary":"It’s Misaligned","date_modified":"2026-04-27T15:34:30Z"},{"id":"https://resetrealignrestart.com/newsletter/f/execution-is-the-new-competitive-advantage-in-biotech","html_content":"

Using Reset · Realign · Restart to Move from Potential to Performance

","url":"https://resetrealignrestart.com/newsletter/f/execution-is-the-new-competitive-advantage-in-biotech","title":"Execution Is the New Competitive Advantage in Biotech","summary":"Using Reset · Realign · Restart to Move from Potential to Performance","date_modified":"2026-04-20T13:26:43Z"},{"id":"https://resetrealignrestart.com/newsletter/f/execution-why-reset-realign-restart-with-sites-drives-success","html_content":"

Why Biotech Must Reset, Realign, and Restart with Clinical Trial Sites

","url":"https://resetrealignrestart.com/newsletter/f/execution-why-reset-realign-restart-with-sites-drives-success","title":" Execution: Why Reset, Realign, Restart with Sites Drives Success","summary":"Why Biotech Must Reset, Realign, and Restart with Clinical Trial Sites","date_modified":"2026-04-06T12:48:21Z"},{"id":"https://resetrealignrestart.com/newsletter/f/why-performance-improves-when-roles-match-decision-making-authori","html_content":"

Reset · Realign · Restart

","url":"https://resetrealignrestart.com/newsletter/f/why-performance-improves-when-roles-match-decision-making-authori","title":"Why Performance Improves When Roles Match Decision-Making Authori","summary":"Reset · Realign · Restart","date_modified":"2026-03-30T13:53:17Z"},{"id":"https://resetrealignrestart.com/newsletter/f/when-high-performance-becomes-the-risk","html_content":"

When High Performance Becomes the Risk: A Case for Reset · Realign · Restart

","url":"https://resetrealignrestart.com/newsletter/f/when-high-performance-becomes-the-risk","title":"When High Performance Becomes the Risk: ","summary":"When High Performance Becomes the Risk: A Case for Reset · Realign · Restart","date_modified":"2026-03-23T17:51:50Z"},{"id":"https://resetrealignrestart.com/newsletter/f/when-the-conditions-break-you-reset-%C2%B7-realign-%C2%B7-restart","html_content":"

This past weekend, I crossed the finish line of Ironman Puerto Rico.

","url":"https://resetrealignrestart.com/newsletter/f/when-the-conditions-break-you-reset-%C2%B7-realign-%C2%B7-restart","title":"When the Conditions Break You, Reset · Realign · Restart","summary":"This past weekend, I crossed the finish line of Ironman Puerto Rico.","date_modified":"2026-03-17T14:04:24Z"},{"id":"https://resetrealignrestart.com/newsletter/f/from-reactive-site-to-precision-site-reset-%C2%B7-realign-%C2%B7-restart","html_content":"

Operational Architecture

","url":"https://resetrealignrestart.com/newsletter/f/from-reactive-site-to-precision-site-reset-%C2%B7-realign-%C2%B7-restart","title":"From Reactive Site to Precision Site: Reset · Realign · Restart ","summary":"Operational Architecture","date_modified":"2026-03-09T15:02:22Z"},{"id":"https://resetrealignrestart.com/newsletter/f/risk-architecture-model-for-clinical-trial-planning","html_content":"

Clinical trial failures rarely begin in execution.\nThey begin in planning.

","url":"https://resetrealignrestart.com/newsletter/f/risk-architecture-model-for-clinical-trial-planning","title":"Risk Architecture Model for Clinical Trial Planning","summary":"Clinical trial failures rarely begin in execution.\nThey begin in planning.","date_modified":"2026-03-04T18:48:23Z"},{"id":"https://resetrealignrestart.com/newsletter/f/making-judgment-visible-the-leadership-skill-that-scales-culture","html_content":"

I have seen this pattern repeatedly in clinical operations.

","url":"https://resetrealignrestart.com/newsletter/f/making-judgment-visible-the-leadership-skill-that-scales-culture","title":"Making Judgment Visible: The Leadership Skill That Scales Culture","summary":"I have seen this pattern repeatedly in clinical operations.","date_modified":"2026-02-23T16:39:15Z"},{"id":"https://resetrealignrestart.com/newsletter/f/reset-%C2%B7-realign-%C2%B7-restart-leadership-beyond-the-routine","html_content":"

This weekend, I stepped away from my routine.

","url":"https://resetrealignrestart.com/newsletter/f/reset-%C2%B7-realign-%C2%B7-restart-leadership-beyond-the-routine","title":"Reset · Realign · Restart: Leadership Beyond the Routine","summary":"This weekend, I stepped away from my routine.","date_modified":"2026-02-16T15:59:06Z"},{"id":"https://resetrealignrestart.com/newsletter/f/leadership-influence-isn%E2%80%99t-about-doing-more-it%E2%80%99s-about-making-re","html_content":"

In many organizations, leadership visibility is still misunderstood.\nIt’s often equated with activity: more meetings, faster responses, constant presence. Leaders are praised for being everywhere, involved in everything,...

","url":"https://resetrealignrestart.com/newsletter/f/leadership-influence-isn%E2%80%99t-about-doing-more-it%E2%80%99s-about-making-re","title":"Leadership Influence Isn’t About Doing More, It’s About Making Re","summary":"In many organizations, leadership visibility is still misunderstood.\nIt’s often equated with activity: more meetings, faster responses, constant presence. Leaders are praised for being everywhere, involved in everything,...","date_modified":"2026-02-09T21:58:38Z"},{"id":"https://resetrealignrestart.com/newsletter/f/reset-is-not-quitting-why-high-performers-need-strategic-pause","html_content":"

If you’re reading this, chances are you’re not someone who gives up easily.

","url":"https://resetrealignrestart.com/newsletter/f/reset-is-not-quitting-why-high-performers-need-strategic-pause","title":"Reset Is Not Quitting: Why High Performers Need Strategic Pause","summary":"If you’re reading this, chances are you’re not someone who gives up easily.","date_modified":"2026-02-02T19:34:59Z"}]}